Prognostic Value of Platelet-to-Platelet Distribution Width Ratio in Postoperative Patients with Type A Acute Aortic Dissection

PPR is a Prognostic Factor in Type A AAD

Authors

  • Yaman Wang, BA Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
  • Xiaohong Xia, BA Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
  • Qing Li, MD Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
  • Gaoxia Ge, MD Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
  • Jun Zhou, MD Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

DOI:

https://doi.org/10.1532/hsf.4605

Keywords:

acute, platelet, platelet distribution width, type A aortic dissection, in-hospital mortality

Abstract

Objective: Acute type A aortic dissection (AAD) is a serious life-threatening cardiovascular emergency with high in-hospital mortality without aggressive clinical treatment. The study intended to identify the relationship between platelet (PLT) to platelet distribution width (PDW) ratio (PPR) and in-hospital mortality in postoperative patients with type A AAD.

Methods: A total of 171 type A AAD patients were recruited in this retrospective study from January 2017 to December 2019. Receiver operating characteristics (ROC) were exploited to determine the best cut-off value of PPR, and then patients were sub-grouped into the low-PPR group and high-PPR group, according to the optimal value of PPR. Finally, univariate, and multivariate analyses were carried out to examine the prognostic value of PPR.

Results: The value of PPR was 9.76, and the mortality was statistically higher in the low-PPR group than in the high-PPR group (29.1% vs. 6.0%, P < 0.01). The area under the ROC curve (AUC) of PPR was 0.724 (95% CI, 0.633-0.815; P < 0.001) with a 56.4% sensitivity and 80.6% specificity. Multivariate analysis showed that serum PPR was an independent factor associated with in-hospital mortality (hazard ratio (HR): 1.151; 95% confidence interval (CI): 1.035 -1.297; P = 0.010).

Conclusion: Serum PPR can be used as an independent predictor of in-hospital mortality in postoperative patients with type A AAD.

References

Akutsu K, Sato N, Yamamoto T, Morita N, Takagi H, Fujita N, et al. 2005. A rapid bedside D-dimer assay (cardiac D-dimer) for screening of clinically suspected acute aortic dissection. Circ J. 69(4), 397-403.

Carnevale D, Lembo G, Frati G. 2011. Chronic Type A aortic dissection: could surgical intervention be guided by molecular markers? J Cell Mol Med. 15(7), 1615-1619.

De Leon Ayala IA, Chen YF. 2012. Acute aortic dissection: an update. Kaohsiung J Med Sci. 28(6), 299-305.

Du R, Li D, Yu J, Ma Y, Zhang Q, Zeng Z, Zeng R. 2017. Association of platelet to lymphocyte ratio and risk of in-hospital mortality in patients with type B acute aortic dissection. Am J Emerg Med. 35(2), 368-370.

Gao Y, Li D, Cao Y, Zhu X, Zeng Z, Tang L. 2019. Prognostic value of serum albumin for patients with acute aortic dissection: A retrospective cohort study. Medicine (Baltimore). 98(6), e14486.

Gardiner EE, Andrews RK. 2014. Structure and function of platelet receptors initiating blood clotting. Adv Exp Med Biol. 844, 263-275.

Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. 2011. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 17(1), 47-58.

Golebiewska EM, Poole AW. 2015. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev. 29(3), 153-162.

Huang B, Tian L, Fan X, Zhu J, Liang Y, Yang Y. 2014. Low admission platelet counts predicts increased risk of in-hospital mortality in patients with type A acute aortic dissection. Int J Cardiol. 172(3), e484-486.

Kamisli O, Kamisli S, Kablan Y, Gonullu S, Ozcan C. 2013. The prognostic value of an increased mean platelet volume and platelet distribution width in the early phase of cerebral venous sinus thrombosis. Clin Appl Thromb Hemost. 19(1), 29-32.

Le VB, Schneider JG, Boergeling Y, Berri F, Ducatez M, Guerin JL, et al. 2015. Platelet activation and aggregation promote lung inflammation and influenza virus pathogenesis. Am J Respir Crit Care Med. 191(7), 804-819.

Li D, Ye L, Yu J, Deng L, Liang L, Ma Y, et al. 2017. Significance of the thrombo-inflammatory status-based novel prognostic score as a useful predictor for in-hospital mortality of patients with type B acute aortic dissection. Oncotarget. 8(45), 79315-79322.

Li DZ, Chen QJ, Sun HP, Zeng R, Zeng Z, Gao XM, et al. 2016. Mean platelet volume to platelet count ratio predicts in-hospital complications and long-term mortality in type A acute aortic dissection. Blood Coagul Fibrinolysis. 27(6), 653-659.

Li DZ, Yu J, Du RS, Zeng R, Zeng Z. 2016. Thrombo-inflammatory status and prognosis of acute type A aortic dissection. Herz. 41(3), 250-251.

Liu JP, Wang YM, Zhou J. 2019. Platelet parameters aid identification of adult-onset Still's disease from sepsis. Neth J Med. 77(8), 274-279.

Luo F, Zhou XL, Li JJ, Hui RT. 2009. Inflammatory response is associated with aortic dissection. Ageing Res Rev. 8(1), 31-35.

Nienaber CA, Clough RE, Sakalihasan N, Suzuki T, Gibbs R, Mussa F, et al. 2016. Aortic dissection. Nat Rev Dis Primers. 2, 16071.

Semple JW, Italiano JE, Jr., Freedman J. 2011. Platelets and the immune continuum. Nat Rev Immunol. 11(4), 264-274.

Tsai TT, Trimarchi S, Nienaber CA. 2009. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 37(2), 149-159.

Zhang Z, Xu X, Ni H, Deng H. 2014. Platelet indices are novel predictors of hospital mortality in intensive care unit patients. J Crit Care. 29(5), 885 e881-886.

Published

2022-05-31

How to Cite

wang, yaman, xia, xiaohong, li, qing, ge, gaoxia, & zhou, jun. (2022). Prognostic Value of Platelet-to-Platelet Distribution Width Ratio in Postoperative Patients with Type A Acute Aortic Dissection: PPR is a Prognostic Factor in Type A AAD. The Heart Surgery Forum, 25(3), E413-E416. https://doi.org/10.1532/hsf.4605

Issue

Vol. 25 No. 3 (2022)

Section

Articles

Author Disclosure & Copyright Transfer Agreement

In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.

A current form follows:

The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.

However, Publisher grants back to the author(s) the following:

  1. The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
  2. The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
  3. The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
  4. The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
  5. The right to make oral presentations of material from this work.

Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.

I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.

I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).

I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.

Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).